National Centre for Pharmacoeconomics

National Centre for

NCPE Ireland

Grass pollen allegen extract (Oralair®) for the treatment of allergic grass pollen rhinitis with or without conjunctivitis in adults, adolescents and children (above the age of 5) with clinically relevant symptoms confirmed by a positive cutaneous test and/or a positive titre of the specific IgE to the grass pollen.

Rapid Review

Commenced Completed Outcome
26/09/2011 October 2011 Full Pharmacoeconomic Evaluation not Recommended